Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Lab Grown Meat Labeling topic
No spam. Unsubscribe anytime.
Committee debates labeling choices for proposed lab‑grown meat disclosure law; substitute adopted
Summary
A bill requiring clear labeling of lab‑grown or cell‑cultured meat products drew discussion on terminology and federal preemption; the committee adopted a substitute and discussed coordinating with USDA/FDA standards.
Representative Alexander presented a bill to the Michigan House Agriculture Committee that would require products derived from animal cells in laboratory processes to be labeled so consumers can distinguish them from conventionally raised meat.
“Consumers across the state deserve to know what they're buying,” Representative Alexander said, describing the proposal as a transparency measure. He compared the proposal to prior federal action on plant‑based milk labels and said the state should use clear language to avoid consumer confusion.
The committee adopted Substitute H‑1 for House Bill 4,076 by roll call. The clerk recorded the substitution vote as 10 yeas, 0 nays, 0 passes. Committee discussion then focused on how to phrase a required disclaimer, which terms to use (examples offered in the substitute included “lab grown,” “cell‑cultivated” and “cultured”), and whether federal standards from USDA or FDA might supersede state law.
Representative Reinegans asked what prompted the bill; Alexander said other states have adopted similar language and that matching commonly used state language would help create uniformity until a federal standard exists. Representative Skaggs asked whether USDA might establish a nationwide label and how this state bill would interact with that. Alexander said he was using language similar to other states with the expectation the committee could later align with federal standards when they appear.
Representative Devendorff asked about the range of label terms in the substitute and whether a single preferred term exists at the federal level; Alexander said there is no settled federal term and that the substitute cast a wider net to cover several currently used labels in the product development stage.
The committee also discussed a numeric example in the substitute that would allow certain products that contain less than 20% animal‑cell protein to be labeled in a particular way; members asked for clarification about the choice of 20 percent. Alexander said the 20 percent figure was a starting point used in some drafts to define early formulations of the product "and that’s roughly what they used to start it with." The discussion did not change the committee’s recorded vote adopting the substitute.
No opponent testimony was recorded in the transcript; written support and opposition cards appeared in committee materials but the committee did not take additional votes on final passage during this session.
